Aprima Medical Software, Inc

Upsher-Smith Launches Clonidine Hydrochloride Extended-release Tablets
Materials

Upsher-Smith Launches Clonidine Hydrochloride Extended-release Tablets

Maple Grove, Minn., Jan. 28, 2020 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clonidine Hydrochloride Extended-Release Tablets in 0.1 mg strength. Upsher-Smith's product is AB1-rated to the branded product, KAPVAY® (clonidine hydrochloride) extended-release tablets*. The clonidine hydrochloride extended-release tablet market had U.S. sales of...

Read More »
Upsher-Smith Launches Clonidine Hydrochloride Extended-release Tablets
Materials

Upsher-Smith Launches Clonidine Hydrochloride Extended-release Tablets

Maple Grove, Minn., Jan. 28, 2020 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clonidine Hydrochloride Extended-Release Tablets in 0.1 mg strength. Upsher-Smith's product is AB1-rated to the branded product, KAPVAY® (clonidine hydrochloride) extended-release tablets*. The clonidine hydrochloride extended-release tablet market had U.S. sales of...

Read More »

All Topics